Related Experiment Video
Updated: Oct 13, 2025

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
Dimethyl fumarate prevents acute lung injury related cognitive impairment potentially via reducing inflammation
Xiaowei Wang1, Yanbo Wang2, Haiyan Pan3
1Department of Respiratory, The Third Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou City, 310000, Zhejiang Province, China.
Objective:
Dimethyl fumarate (DMF) has been reported to exert a protective role against diverse lung diseases and cognitive impairment-related diseases. Thus this study aimed to investigate its role on acute lung injury (ALI) and related cognitive impairment in animal model.
Methods:
C57BL/6 mice were divided into four groups: control group, DMF group, ALI group, and ALI + DMF group. For ALI group, the ALI mice model was created by airway injection of LPS (50 μL, 1 μg/μL); for ALI + DMF group, DMF (dissolved in 0.08% methylcellulose) was treated twice a day for 2 days, and on the third day, mice were injected with LPS for ALI modeling. Mice pre-administered with methylcellulose or DMF without LPS injection (PBS instead) were used as the control group and DMF group, respectively. Morris water maze test was performed before any treatment (0 h) and 6 h after LPS-induction (54 h) to evaluate the cognitive impairment of mice. Next, the brain edema and blood brain barrier (BBB) permeability of ALI mice were assessed by brain water content, Evans blue extravasation and FITC-Dextran uptake assays. In addition, the effect of DMF on the numbers of total cells and neutrophils, protein content in BALF were quantified; the inflammatory factors in BALF, serum, and brain tissues were examined by ELISA, qRT-PCR, and Western blot assays. The effect of DMF on the cognitive impairment-related factor HIF-1α level in lung and brain tissues was also examined by Western blot.
Results:
DMF reduced the numbers of total cells, neutrophils and protein content in BALF of ALI mice, inhibited the levels of IL-6, TNF-α and IL-1β in BALF, serum and brain tissues of ALI mice. The protein expressions of p-NF-κB/NF-κB and p-IKBα/IKBα was also suppressed by DMF in ALI mice. Morris water maze test showed that DMF alleviated the cognitive impairment in ALI mice by reducing the escape latency and path length. Moreover, DMF lessened the BBB permeability by decreasing cerebral water content, Evans blue extravasation and FITC-Dextran uptake in ALI mice. The HIF-1α levels in lung and brain tissues of ALI mice were also lessened by DMF.
Conclusion:
In conclusion, DME had the ability to alleviate the lung injury and cerebral cognitive impairment in ALI model mice. This protective effect partly associated with the suppression of inflammation by DMF.
Insights
Dimethyl fumarate (DMF) treatment alleviated acute lung injury (ALI) and associated cognitive impairment in a mouse model. This protective effect was linked to reduced inflammation and improved brain function.
Area of Science:
- Pulmonary Medicine
- Neuroscience
- Pharmacology
Background:
- Dimethyl fumarate (DMF) shows promise in treating lung and cognitive diseases.
- Acute Lung Injury (ALI) can lead to systemic inflammation and cognitive deficits.
Purpose of the Study:
- To investigate the protective effects of DMF on ALI and related cognitive impairment in a mouse model.
- To explore the underlying mechanisms of DMF's action.
Main Methods:
- An ALI mouse model was induced using lipopolysaccharide (LPS).
- Mice were treated with DMF or a placebo.
- Cognitive function was assessed using the Morris water maze test.
- Lung injury markers, brain edema, blood-brain barrier (BBB) permeability, and inflammatory factors were analyzed.
Main Results:
- DMF significantly reduced inflammatory cell counts and protein levels in bronchoalveolar lavage fluid (BALF).
- DMF suppressed key inflammatory cytokines (IL-6, TNF-α, IL-1β) in BALF, serum, and brain tissue.
- DMF treatment improved cognitive performance in ALI mice, reducing escape latency and path length.
- DMF mitigated BBB permeability and brain edema.
- DMF downregulated HIF-1α expression in lung and brain tissues.
Conclusions:
- Dimethyl fumarate (DMF) demonstrates significant therapeutic potential for mitigating acute lung injury (ALI) and associated cognitive impairment.
- DMF's protective effects are partly attributed to its anti-inflammatory properties.
- Further research into DMF as a treatment for ALI-induced cognitive dysfunction is warranted.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...

